Oneness Financial Statements From 2010 to 2024

4743 Stock  TWD 101.50  3.50  3.33%   
Oneness Biotech financial statements provide useful quarterly and yearly information to potential Oneness Biotech Co investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Oneness Biotech financial statements helps investors assess Oneness Biotech's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Oneness Biotech's valuation are summarized below:
Oneness Biotech Co does not presently have any trending fundamental ratios for analysis.
Check Oneness Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oneness Biotech's main balance sheet or income statement drivers, such as , as well as many indicators such as . Oneness financial statements analysis is a perfect complement when working with Oneness Biotech Valuation or Volatility modules.
  
This module can also supplement various Oneness Biotech Technical models . Check out the analysis of Oneness Biotech Correlation against competitors.

Oneness Biotech Co Company Current Valuation Analysis

Oneness Biotech's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Oneness Biotech Current Valuation

    
  92.26 B  
Most of Oneness Biotech's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Oneness Biotech Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Oneness Biotech Co has a Current Valuation of 92.26 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The current valuation for all Taiwan stocks is significantly lower than that of the firm.

Oneness Biotech Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Oneness Biotech's current stock value. Our valuation model uses many indicators to compare Oneness Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oneness Biotech competition to find correlations between indicators driving Oneness Biotech's intrinsic value. More Info.
Oneness Biotech Co is rated fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Oneness Biotech's earnings, one of the primary drivers of an investment's value.

About Oneness Biotech Financial Statements

Oneness Biotech investors use historical fundamental indicators, such as Oneness Biotech's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Oneness Biotech. Please read more on our technical analysis and fundamental analysis pages.

Pair Trading with Oneness Biotech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Oneness Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oneness Biotech will appreciate offsetting losses from the drop in the long position's value.

Moving together with Oneness Stock

  0.966547 Medigen Vaccine BiologicsPairCorr
  0.854174 OBI PharmaPairCorr

Moving against Oneness Stock

  0.872891 CTBC Financial HoldingPairCorr
  0.812891B CTBC Financial HoldingPairCorr
  0.742883 China DevelopmentPairCorr
  0.694162 PharmaEnginePairCorr
  0.582330 Taiwan SemiconductorPairCorr
The ability to find closely correlated positions to Oneness Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Oneness Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Oneness Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Oneness Biotech Co to buy it.
The correlation of Oneness Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Oneness Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Oneness Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Oneness Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Oneness Stock Analysis

When running Oneness Biotech's price analysis, check to measure Oneness Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oneness Biotech is operating at the current time. Most of Oneness Biotech's value examination focuses on studying past and present price action to predict the probability of Oneness Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oneness Biotech's price. Additionally, you may evaluate how the addition of Oneness Biotech to your portfolios can decrease your overall portfolio volatility.